Loading insider details...
Latest Form 4 (Nov 14, 2026): Sale of 250,804 STIM shares, $599.4K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 14, 2026 | Neuronetics, Inc. (STIM) | Sale | 250,804 | $599.4K |
| Nov 14, 2026 | EXAGEN INC. (XGN) | Sale | 109,436 | $508.9K |
| Nov 14, 2026 | Starling Oncology, Inc. (STLN) | Purchase | 1,391 | $1.1K |
| Nov 12, 2026 | Starling Oncology, Inc. (STLN) | Purchase | 1,391 | $1.1K |
| Nov 11, 2026 | EXAGEN INC. (XGN) | Sale | 11,265 | $69.2K |
| Nov 10, 2026 | Starling Oncology, Inc. (STLN) | Sale | 2,851,061 | $11.38M |
| Nov 2, 2026 | Neuronetics, Inc. (STIM) | Purchase | 18,000 | $40.9K |
| Oct 20, 2026 | EXAGEN INC. (XGN) | Purchase | 14,000 | $104.4K |
| Aug 17, 2026 | Neuronetics, Inc. (STIM) | Purchase | 14,000 | $44.2K |
| Aug 17, 2026 | Starling Oncology, Inc. (STLN) | Purchase | 12,000 | $78.5K |